BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210929
DTEND;VALUE=DATE:20211001
DTSTAMP:20210923T222435Z
CREATED:20210923T222435Z
LAST-MODIFIED:20210923T222435Z
UID:49739-1632873600-1633046399@globalbiodefense.com
SUMMARY:Medical Biomedical Biodefense: Support to the Warfighter Virtual Symposium
DESCRIPTION:The Medical\, Biomedical & Biodefense: Support to the Warfighter Virtual Symposium will be held 29-30 September 2021. \nThe Fort Bragg Research Institute will host senior medical leaders from Fort Bragg for a discussion on near-term medical requirements for operations in contested battlespace and the health care vision for the next-generation warfighter. \nA panel of experts will bring key insights gleaned from the role they or their organization played over the last year of responding to the COVID-19 pandemic and explore the ways government agencies\, companies and non-profit organizations can all play a critical role in preparing us for the future. \nPanel presenters will identify requirements of VA medical centers and clinics in the region for medical products and services\, including research and development\, supplies\, equipment\, devices\, pharmaceuticals\, training\, IT and staff augmentation. \nHuman Performance Optimization Advanced Technology Showcase (HPO ATS) \nAs part of the MBB Symposium\, the North Carolina Defense Technology Transition Office (DEFTECH) and the NC Center for Optimizing Military Performance (NC-COMP) will conduct an HPO Advanced Technology Showcase. DEFTECH will release a “Request for Technologies – RFT” addressing a broad range of HPO R&D areas. \nHOSTED BY: \n\nOffice of United States Senator Richard Burr\nOffice of United States Senator Thom Tillis\nNorth Carolina Military Business Center\nNorth Carolina Biotechnology Center\nUNC System\n\nSYMPOSIUM PARTNERS. \n\nNorth Carolina Defense Technology Transition Office (DEFTECH)\nNorth Carolina Center for Optimizing Military Performance (NC-COMP)\nDefense Alliance of North Carolina\n\nLEARN MORE: https://mbb.ncmbc.us/event-info/
URL:https://globalbiodefense.com/event/medical-biomedical-biodefense-support-to-the-warfighter-virtual-symposium/
LOCATION:
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210929
DTEND;VALUE=DATE:20210930
DTSTAMP:20210919T003055Z
CREATED:20210919T003055Z
LAST-MODIFIED:20210919T003055Z
UID:49670-1632873600-1632959999@globalbiodefense.com
SUMMARY:TEI-REX Proposer's Day
DESCRIPTION:The Intelligence Advanced Research Projects Activity (IARPA) will hold a virtual Proposers’ Day for the TEI-REX Program (Targeted Evaluation of Ionizing Radiation Exposure) on September 29\, 2021 from 10:00 am to 5:00 pm EDT with potential overflow into September 30\, 2021 from 10:00 am to 1:00 pm. \nThe TEI-REX Proposers’ Day meeting will be used to introduce the research requirements to potential performers and provide information on program objectives. The TEI-REX Program aims to establish novel biodosimetry approaches enabling improved quantification of low-dose ionizing radiation exposures (<0.75 Gray) from minimally and non-invasive samples\, while also expanding quantitative and qualitative knowledge of the exposure environment. \nIARPA holds Proposers’ Days to provide information to assist potential proposers to evaluate whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. The TEI-REX Proposers’ Day is open only to registered potential proposers\, and not to the media or the general public. \nThe meeting will be held entirely on the WebEx video conference platform\, and a recorded video of the meeting will be made available to the public on the IARPA website. \nPre-registration is required and closes on September 24\, 2021 at 5:00 pm EDT. \nOpportunities to facilitate teaming are available to registrants for the TEI-REX Proposers’ Day. IARPA highly encourages potential proposers to establish strong teams capable of addressing the technical challenges TEI-REX aims to overcome. \nThis meeting will include an introduction to IARPA\, an overview of the program\, technical challenges\, and expected participation requirements. Before the Proposers’ Day meeting\, attendees may submit comments or questions regarding TEI-REX by emailing the program manager (contact information at the event link).
URL:https://globalbiodefense.com/event/tei-rex-proposers-day/
LOCATION:
CATEGORIES:Government Hosted,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T110000
DTEND;TZID=America/New_York:20210928T130000
DTSTAMP:20210925T183006Z
CREATED:20210915T181953Z
LAST-MODIFIED:20210925T183006Z
UID:49861-1632826800-1632834000@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will convene to discuss the strategy and planning for the National Special Pathogen System and other high priority issues related to national public health emergency preparedness and response. \nThe meeting is open to the public and will be held in a virtual format on September 28\, 2021. The NBSB invites those who are involved in or represent a relevant industry\, academia\, health profession\, health care consumer organization\, or state\, Tribal\, territorial or local government to request up to seven minutes to address the board in person via Zoom. \nRequests to provide remarks to the NBSB during the public meeting may be sent to NBSB@hhs.gov. Please include the name of the speaker\, organization\, and a full explanation of the intended comments. Please submit your request by 5PM ET on September 24\, 2021. \nABOUT THE NBSB \nThe National Biodefense Science Board (NBSB or the Board) is authorized under Section 319M of the Public Health Service (PHS) Act\, as added by Section 402 of the Pandemic and All-Hazards Preparedness Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards Preparedness Reauthorization Act. The Board is governed by the Federal Advisory Committee Act\, which sets forth standards for the formation and use of advisory committees. The NBSB provides expert advice and guidance on scientific\, technical\, and other matters of special interest to the Department regarding current and future chemical\, biological\, nuclear\, and radiological agents\, whether naturally occurring\, accidental\, or deliberate. \nMembers of the public may attend the meeting via a toll-free phone number or Zoom teleconference\, which requires pre-registration. The meeting link to pre-register will be posted on https://www.phe.gov/​nbsb. Members of the public may provide written comments or submit questions for consideration by the NBSB at any time via email to NBSB@hhs.gov. Members of the public are also encouraged to provide comments after the meeting.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-2/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T090000
DTEND;TZID=America/New_York:20210928T103000
DTSTAMP:20210925T165652Z
CREATED:20210925T165502Z
LAST-MODIFIED:20210925T165652Z
UID:49848-1632819600-1632825000@globalbiodefense.com
SUMMARY:Launch of the Defeating Meningitis by 2030 Roadmap
DESCRIPTION:The impact of meningitis is as profound as it is diverse: it can kill within hours\, disrupts health\nsystems\, impedes education and child development\, devastates families and communities\, and causes\nlifelong disabilities. Meningitis epidemics are unpredictable and can strike anywhere\, affecting people\nof any age\, including healthy children and young adults. \nDespite successful efforts to control meningitis in several regions\, meningitis continues to be a major public health issue. It kills about 250 000 people annually\, and leaves 1 in 5 of those affected with long-term devastating sequelae. \nDr Tedros Adhanom Ghebreyesus\, Director-General of the World Health Organization and partners will be launching Defeating Meningitis by 2030: A Global Road Map on: Tuesday\, 28 September 2021.   \nThe meningitis road map—developed though a robust\, multidisciplinary consultation process—\nrepresents an unprecedented opportunity to channel the wave of “defeat meningitis” momentum\ninto a concrete plan of action. Defeating meningitis is not only feasible\, but also critical to the\nachievement of the Sustainable Development Goals (SDGs) and will strengthen many aspects of the\nhealth system – from disease surveillance\, to immunization\, to primary health care and universal\nhealth coverage\, to improving services for persons living with disabilities. \nImplementing the road map is how the global community will come together to defeat meningitis. The five pillars of the road map each address a critical need in the fight against meningitis: prevention and epidemic control\, prompt diagnosis and treatment\, disease surveillance\, support and care for people (and families) affected by meningitis\, and advocacy and engagement. How do we leverage the road map to facilitate impact? This panel will share some of the major strides we have already made and provide a view on what the future holds. \nPlease visit the WHO’s Launch of the Defeating Meningitis Roadmap website for more information
URL:https://globalbiodefense.com/event/launch-of-the-defeating-meningitis-by-2030-roadmap/
LOCATION:
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/world-health-defeating-meningitis-global-road-map.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20210929
DTSTAMP:20210925T172033Z
CREATED:20210925T171954Z
LAST-MODIFIED:20210925T172033Z
UID:49851-1632787200-1632873599@globalbiodefense.com
SUMMARY:World Rabies Day
DESCRIPTION:World Rabies Day is observed annually to raise awareness about rabies prevention and to highlight progress in defeating this horrifying disease. \nEstablished in 2007\, it aims to raise awareness about rabies and help the world come together to fight this highly fatal\, neglected disease. The theme for 2021 is ‘Rabies: Facts\, not Fear\,’ focusing on: \n\nThe knowledge\, strategies\, and tools to eliminate dog-mediated rabies.\nSuccessful approaches and tools to prevent\, control and eliminate the disease.\nSaving lives by spreading awareness about rabies\, and teaching others how to prevent it.\n\n28 September also marks the anniversary of Louis Pasteur’s death\, the French chemist and microbiologist\, who developed the first rabies vaccine. \nRabies is estimated to cause 59\,000 human deaths annually in over 150 countries\, with 95% of cases occurring in Africa and Asia. Due to underreporting and uncertain estimates\, this number is likely a gross underestimate. The burden of disease is disproportionally borne by rural poor populations\, with approximately half of cases attributable to children under 15 years of age. \nToday\, safe and efficacious animal and human vaccines are among the important tools that exist to eliminate human deaths from rabies while awareness is the key driver for success of communities to engage in effective rabies prevention. \nIn the United States\, rabies deaths are very rare thanks to successful animal control and vaccination programs\, and a robust healthcare structure that can provide vaccines to people shortly after an exposure. About 55\,000 Americans get postexposure prophylaxis (PEP) each year to prevent rabies infection after being bitten or scratched by an infected or suspected infected animal. \nRabies is a viral zoonotic disease that causes progressive and fatal inflammation of the brain and spinal cord. Clinically\, it has two forms: \nFurious rabies – characterized by hyperactivity and hallucinations.\nParalytic rabies – characterized by paralysis and coma. \nAlthough fatal once clinical signs appear\, rabies is entirely avoidable; vaccines\, medicines and technologies have long been available to prevent death from rabies. Nevertheless\, rabies still kills tens of thousands of people each year. Of these cases\, approximately 99% are acquired from the bite of an infected dog. \nDog-mediated human rabies can be eliminated by tackling the disease at its source: infected dogs. Making people aware of how to avoid the bites of rabid dogs\, to seek treatment when bitten and to vaccinate animals can successfully disrupt the rabies transmission cycle. \nEarly symptoms of a rabies infection can include a fever with pain and unusual or unexplained tingling\, pricking or burning sensation (paraesthesia) at the wound site. In later states\, the virus spreads to the central nervous system\, causing fatal inflammation of the brain and spinal cord. The incubation period of the disease can vary from 1 week to 1 year\, though it is typically 2–3 months. \nThe two types of rabies show different symptoms. Furious rabies causes signs of hyperactivity\, excitable behaviour\, hydrophobia (fear of water) and sometimes aerophobia (fear of drafts or of fresh air). Death occurs after a few days due to cardio-respiratory arrest. \nParalytic rabies\, which accounts for about 20% of the total number of human cases\, runs a less dramatic and usually longer course than the furious form. Muscles gradually become paralysed\, starting at the site of the bite or scratch. A coma slowly develops and eventually death occurs. The paralytic form of rabies is often misdiagnosed\, contributing to the under-reporting of the disease. \nLearn more about Rabies at the World Health Organization website. \n 
URL:https://globalbiodefense.com/event/world-rabies-day/
LOCATION:Global Biodefense Calendar
CATEGORIES:Awareness Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210927T200000
DTEND;TZID=America/New_York:20210927T220000
DTSTAMP:20210924T000415Z
CREATED:20210902T000135Z
LAST-MODIFIED:20210924T000415Z
UID:49748-1632772800-1632780000@globalbiodefense.com
SUMMARY:Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication
DESCRIPTION:The intentional or unintentional spread of inaccurate and misleading information during infectious disease outbreaks has become commonplace. Such campaigns can undermine outbreak response activities in affected areas and discredit national\, regional\, and international leaders in biosecurity and health security from a variety of countries and international organizations. The U.S. National Academies of Sciences\, Engineering\, and Medicine convened a committee of experts from the United States and Southeast Asia to serve on a study committee that will analyze how scientists can determine which claims may be addressed by defensible scientific information and how scientists can work together to address those claims. The study will result in a strategy for developing an international network of scientists to address inaccurate and misleading claims. \nThe meeting is intended to focus on determining how to engage scientists in a trusted network to build a defensible\, accurate scientific knowledge-base that could be used to counter false claims\, and developing a guide to help scientists identify and address such claims. This meeting\, any input provided\, and any discussions are designed to benefit Central and Southeast Asia. U.S. participants of the meeting should plan to provide needed input to support the overarching goal of the study to benefit the region. \nThe registration deadline has passed for this open session meeting on September 27\, 2021 from 8:00 – 10:00 PM ET. Please contact both Dr. Kavita Berger (KBerger@nas.edu) and Dr. Jenell Walsh-Thomas (JWalsh-Thomas@nas.edu) if you have any questions about this meeting.
URL:https://globalbiodefense.com/event/addressing-inaccurate-and-misleading-information-about-biological-threats-through-scientific-collaboration-and-communication/
LOCATION:
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210927T123000
DTEND;TZID=America/New_York:20210927T163000
DTSTAMP:20240623T230830Z
CREATED:20210916T000655Z
LAST-MODIFIED:20240623T230830Z
UID:49750-1632745800-1632760200@globalbiodefense.com
SUMMARY:NASEM Committee on Toxicology Annual Meeting
DESCRIPTION:The National Acadamies’ Committee on Toxicology (COT) is a standing committee established in 1947 to provide independent\, authoritative scientific advice to the U.S. military and other agencies on environmental and occupational health questions. Under a contract with the Department of Defense (DOD)\, COT provides advice on toxicological matters by evaluating hazards and health implications of specific product uses and recommending tolerable or emergency exposure guidance levels for chemicals under specific conditions. \nCOT meets at least once a year to review the progress of its committees addressing the tasks assigned by DOD. It also communicates through various other means with representatives of DOD and other agencies to keep abreast of developing requirements and problems\, emerging issues\, and newly initiated research and technology. \nThe committee will discuss whether there may be a need to update any Exposure Guideline Levels because of new toxicological data or understandings\, or to address women’s greater military participation. The committee will overview of the state-of-the science on effects\, levels at which they occur\, animal models\, mechanisms\, and potential for complicating co-exposures. The presentation and discussion will lay the groundwork for potential future conversations with DOD about occupational limit setting. \n\nExposure Guideline Levels: Needs for Updates?\nShort Talk: Submarine Environment Perspective on Women of Child-Bearing Age\nStudy Update: Guidance on PFAS Testing and Health Outcomes\nDiscussion: Toxicology Needs and Challenges at Department of Defense\n\nPlease visit the 2021 Committee on Toxicology Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/nasem-committee-on-toxicology-annual-meeting/
LOCATION:
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210927T120000
DTEND;TZID=America/New_York:20210927T140000
DTSTAMP:20210924T003101Z
CREATED:20210906T002704Z
LAST-MODIFIED:20210924T003101Z
UID:49752-1632744000-1632751200@globalbiodefense.com
SUMMARY:Evolving Crisis Standards of Care and Ongoing Lessons from COVID-19
DESCRIPTION:COVID-19 has fundamentally challenged the delivery of health care services worldwide\, forcing difficult choices on health professionals and laying bare many preexisting health\, medical\, and public health sector frailties. This National Academies workshop series will re-explore previous IOM Crisis Standards of Care recommendations in light of ongoing lessons from the COVID-19 pandemic\, with a particular focus on disaster planning\, legal and equity considerations\, and staffing considerations. \nIn the first virtual workshop of the series\, expert panelists will specifically: \n\nRe-examine the definitions and recommendations first outlined in IOM’s 2009 “Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report”\nRe-explore the framework described in IOM’s 2012 report “Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response”\nReflect on pre-COVID-19 “lessons learned”\, and discuss which have been confirmed and/or refuted by the ongoing COVID-19 crisis.\nReflect on the strengths and weaknesses of the CSC framework and activation/implementation guidance in light of our current experiences and challenges with COVID-19.\n\nConfirmed speakers include: \n\nMonica Peek\, MD\, MPH\, Professor of Medicine\, University of Chicago Medicine\nJennifer Piatt\, Deputy Director with the Network for Public Health Law’s Western Region Office\nMike Wargo\, VP for Preparedness & Emergency Operations\, HCA Healthcare’s enterprise\nAnuj Mehta MD\, MD\, Assistant Professor\, University of Colorado\nDan Hanfling\, MD\, Vice President\, Technical Staff\, In-Q-Tel\nCraig Vanderwagen\, MD\, Rear Admiral USPHS – retired\, founding Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services\, and Founder and General Manager of East West Protection\, LLC\n\nPlease visit the National Academies’ Evolving Crisis Standards of Care and Ongoing Lessons from COVID-19 event website for more information.
URL:https://globalbiodefense.com/event/evolving-crisis-standards-of-care-and-ongoing-lessons-from-covid-19/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210925T080000
DTEND;TZID=America/Los_Angeles:20210925T170000
DTSTAMP:20210925T162800Z
CREATED:20210925T162800Z
LAST-MODIFIED:20210925T162800Z
UID:49841-1632556800-1632589200@globalbiodefense.com
SUMMARY:ABRCMS 2021 - Annual Biomedical Research Conference for Minority Students
DESCRIPTION:The Annual Biomedical Research Conference for Minority Students (ABRCMS)\, recipient of the 2019 AIMBE Excellence in STEM Education Award\, is one of the largest communities of underrepresented minorities in science\, technology\, engineering and mathematics. Students attend this conference to present their research\, enhance professional development skills\, explore graduate schools\, and network. Research faculty and program directors play an essential role in mentoring students and learning strategies for facilitating student success. \nLast year\, ABRCMS engaged nearly 4000 attendees through scientific and professional development sessions\, student presentations and networking opportunities. This year\, ABRCMS: The Virtual Experience will deliver timely and relevant content and activities tailored to the current times. You can expect the same ABRCMS conference you have come to love – with opportunities to learn\, share and connect with peers and experts – in a socially distant format. \nPlease visit the ABRCMS 2021 website for more information.
URL:https://globalbiodefense.com/event/abrcms-2021-annual-biomedical-research-conference-for-minority-students/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210924T110000
DTEND;TZID=America/New_York:20210924T180000
DTSTAMP:20210923T225050Z
CREATED:20210901T222906Z
LAST-MODIFIED:20210923T225050Z
UID:49743-1632481200-1632506400@globalbiodefense.com
SUMMARY:Developing a Long-Term Strategy for Low-Dose Radiation Research in the U.S.
DESCRIPTION:Join the Committee on Developing a Long-Term Strategy for Low-Dose Radiation Research in the United States at its third public meeting on Friday\, September 24. The Committee will hear from federal agencies\, research institutes\, and international organizations on coordination of low-dose radiation research. \nHighlighted topics include: \n\nCoordination of Low-Dose Radiation Research with the National Cancer Institute (NCI)\nQ+A with the Committee and Staff\nCoordination of Low-Dose Radiation Research with the Nuclear Energy Agency-Organisation for Economic Cooperation and Development (NEA-OECD)\nCoordination of Low-Dose Radiation Research with the National Institute of Allergy and Infectious Diseases (NIAID)\n\nBACKGROUND \nThe National Academies of Sciences\, Engineering\, and Medicine will perform a study and provide a report with findings and recommendations on the current status and development of a long-term strategy for low-dose radiation research in the United States. Specifically\, the objectives of the study will be to: \n1. Define the health and safety issues that need to be guided by an improved understanding of low dose and low dose rate radiation health effects. \n2. Identify current scientific challenges for understanding low dose and low dose rate radiation health effects. \n3. Assess the status of current low dose radiation research in the United States and internationally. \n4. Recommend a long-term strategic and prioritized research agenda to address scientific research goals for overcoming the identified scientific challenges in coordination with other research efforts and support education and outreach activities to disseminate information and promote public understanding of low-dose radiation. \n5. Define the essential components of the research program that would address this research agenda within the universities and National Laboratories. \n6. Address coordination between federal agencies (including the National Institutes of Health\, the National Science Foundation\, National Aeronautics and Space Administration\, and different DOE offices) and with international efforts to achieve objectives. \n7. Identify and\, to the extent possible\, quantify\, potential monetary and health-related impacts to Federal agencies\, the general public\, industry\, research communities\, and other users of information produced by such research program. \nThe National Academies will prepare a report with findings and recommendations that addresses the objectives above. \nRECOMMENDED READING MATERIAL \n\nA summary of the Occupational Energy Research Program (OERP) studies\n353 NIOSH products about radiation can be found in NIOSHTIC-2\, which is a\nsearchable bibliographic database of occupational safety and health publications\,\nsupported in whole or in part by the National Institute for Occupational Safety and Health\n(NIOSH).\nInternational Dose Effect Alliance (IDEA) Virtual Workshop – December 2\, 2020\nChallenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments. Andrea L. DiCarlo\, David R. Cassatt\, William E. Dowling\, John L. Esker\, Judith A. Hewitt\, Oxana Selivanova\, Mark S. Williams and Paul W. Price. Radiation Research 190\, 659–676 (2018); 0033-7587/18. DOI: 10.1667/RR15137.1.\nCutaneous Radiation Injuries: Models\, Assessment and Treatments. Andrea L. DiCarlo\, Aaron C. Bandremer\, Brynn A. Hollingsworth\, Suhail Kasim\, Adebayo Laniyonu\, Nushin F. Todd\, Sue-Jane Wang\, Ellen R. Wertheimer and Carmen I. Rios. Radiation Research 194\, 315–344 (2020); 0033-7587/20. DOI: 10.1667/RADE-20-00120.1.\nMedical Countermeasures against Nuclear Threats: Radionuclide Decorporation Agents. David R. Cassatt\, Joseph M. Kaminski\, Richard J. Hatchett\, Andrea L. DiCarlo\, Jessica M. Benjamin and Bert W. Maidment. Radiation Research 170\, 540–548 (2008); 0033-7587/08.\nMedical Countermeasures for Platelet Regeneration after Radiation Exposure. Report of a Workshop and Guided Discussion. Andrea L. DiCarlo\, Mortimer Poncz\, David R. Cassatt\, Jui R. Shah\, Christine W. Czarniecki and Bert W. Maidment. Radiation Research 176\, e0001–e0015 (2011); 0033-7587/11. DOI: 10.1667/RROL01.1.\nMedical Countermeasures for Radiation Combined Injury: Radiation with Burn\, Blast\, Trauma and/or Sepsis. Andrea L. DiCarlo\, Richard J. Hatchett\, Joseph M. Kaminski\, G. David Ledney\, Terry C. Pellmar\, Paul Okunieff and Narayani Ramakrishnan. Radiation Research 169\, 712–721 (2008); 0033-7587/08.\nNeutron Radiobiology and Dosimetry. Daniela L. Stricklin\, Jama VanHorne-Sealy\, Carmen I. Rios\, Lisa A. Scott Carnell and Lanyn P. Taliaferro. Radiation Research 195\, 480–496 (2021); 0033-7587/21. DOI: 10.1667/RADE-20-00213.1.\nUse of Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health Emergency. Andrea L. DiCarlo\, Zulmarie Perez Horta\, Jennifer T. Aldrich\, Ann A. Jakubowski\, William K. Skinner and Cullen M. Case\, Jr. Radiation Research 192\, 99–120 (2019); 0033-7587/19. DOI: 10.1667/RR15363.1.\n\nSPEAKER BIOGRAPHIES \nArmin Ansari is the Radiological Assessment Team Lead at the Centers for Disease Control and Prevention (CDC). He received his B.S. and PhD degrees in radiation biophysics from the University of Kansas and completed his postdoctoral research in radiation mutagenesis at Oak Ridge and Los Alamos National Laboratories. His focus since joining CDC in 2002 has been on public health preparedness and response planning for nuclear and radiological emergencies and he has led the development of key national guidance documents as well as numerous training programs directed at public health professionals. He is a fellow and past president of the Health Physics Society and is certified in comprehensive practice by the American Board of Health Physics. He is also an elected member of the National Council on Radiation Protection and Measurements\, and serves as member of the United States delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation. \nAmy Berrington de González\, D.Phil.\, is the Branch Chief of the NCI’s Radiation Epidemiology Branch. She is an internationally recognized expert in the potential cancer risks from medical radiation exposures. Dr. Berrington is co-PI of the UK Pediatric CT scans cohort\, which was the first epidemiological study to suggest a direct link between CT scans and subsequent cancer risk. She also leads studies on the risk of second cancer after proton therapy and other emerging radiotherapy techniques. Dr. Berrington is currently a member of the NAS Nuclear\nand Radiation Studies Board and has participated in many national and international radiation committees. She is an elected member of the American Epidemiological Society and served on the editorial board for the American Journal of Epidemiology. Before joining the NCI in 2008 she held faculty positions at Oxford and Johns Hopkins University. She has a DPhil in Cancer Epidemiology from the University of Oxford. \nC. Norman Coleman\, MD is the Associate Director for the Radiation Research Program in the Division of Cancer Treatment and Diagnosis and a Senior Investigator in the Radiation Oncology Branch in the Center for Cancer Research\, National Cancer Institute\, NIH. He is also a Senior Medical Advisor in the Office of the Assistant Secretary for Preparedness and Response in the US. Department of Health and Human Services. He received his BA in Mathematics ( University of Vermont)\, MD (Yale University School) and is Board Certified in internal medicine (UC San Francisco)\, medical oncology (NCI) and radiation oncology (Stanford). He served in the US Public Health Service (O-4). Dr Coleman became a tenured faculty member in Radiology and Medicine at Stanford (1978 – 1985) and then moved to Harvard Medical School (1985 – 1999) as the Alvan T. and Viola D. Fuller- Medicine Cancer Society Professor and Chairman of the Joint Center for Radiation Therapy. He returned to the NCI in 1999. His interests include an ongoing NCI laboratory program in radiation-inducible molecular targets (using radiation “as a drug”)\, radiation biomarkers of normal tissue injury and multi-modality cancer therapy. His honors include: Gold Medal\, ASTRO (2005)\, Service to America Homeland Security Medal (2011)\, Radiation Research Society Failla Award (2016)\, University of Vermont\, Doctor of Science Honoris Causa (2015) and National Coalition for Cancer Survivorship Ellen Lewis Stovall Patient Centered Cancer Care Award (2018). \nDr. Donald A. Cool\, Ph.D.\, is currently the Technical Executive for Radiation Safety with the Electric Power Research Institute (EPRI). He joined EPRI in 2015 following retirement from the U.S. Nuclear Regulatory Commission\, where he served more than 32 years. Dr. Cool received his B.S. degree in Biology from Houghton College. His Masters and Doctorate degrees are in Radiation Biology from the University of Rochester\, School of Medicine and Dentistry. He is the Vice-Chair of the Main Commission of the International Commission on Radiological Protection. He is a Council Member of the U.S. National Council on Radiation Protection and\nMeasurements and was the Co-Chair of NCRP Council Committee 1 which produced NCRP Report 180\, Management of Exposure to Ionizing Radiation: Radiation Protection Guidance for the United States. He has served on numerous panels and expert groups of the International Atomic Energy Agency and Nuclear Energy Agency. He is a Fellow of the Health Physics Society. \nDr. Sylvain Costes is the Branch Chief for the Space Biosciences Research Branch at NASA Ames research center and a senior research scientist leading the Ames radiation biophysics laboratory. He obtained his Ph.D. in the Nuclear Engineering Department at the University of California\, Berkeley\, where he studied radiation biology. Dr. Costes has spent his career leading multidisciplinary research teams in both academic and government scientific institutions. As a staff scientist at the Lawrence Berkeley National Lab\, he was modeling risk for the NASA Human\nresearch program and developing biomarkers for the DOE low dose program. He is now the project manager for Open Science at NASA Biology and Physical Science Division\, where he leads the systems biology research\, AI/ML modeling effort and the software development for two large NASA data systems: the GeneLab Omics repository and the ALSDA repository for physiological data from spaceflight relevant experiments. \nAndrea DiCarlo earned her doctorate from the University of Maryland\, for work focused on targeting heat shock proteins to reduce oxidative stress caused by ionizing radiation exposures and other stressors. These studies led her to carry out post-doctoral work at The Catholic University of America (CUA)\, where she studied radioprotection of normal tissues in animal models of cancer. While at CUA\, Andrea initiated collaborations with staff from the Armed Forces Radiobiology Research Institute (AFRRI) as well as the Georgetown Lombardi Comprehensive Cancer Center\, and parlayed her postdoctoral work into a position as the Project Manager of the\nlaboratory\, and as a CUA faculty member. In 2004\, Andrea became a Program Officer in the Radiation and Nuclear Countermeasures Program (RNCP) at the National Institute of Allergy and Infectious Diseases (NIAID)\, within the National Institutes of Health (NIH)\, where she was responsible for the oversight and management of a research portfolio exceeding ~$20 million dollars per year. She has published extensively in government reports and peer-reviewed journals on the biological effects of radiation exposure\, testing of medical countermeasures\, and evaluation of biodosimetry devices and biomarkers for triage. Representing NIAID\, she has worked with other US government agencies and non-governmental organizations to highlight and support national and international research activities\, reviewed grant applications and manuscripts\, and has served as a subject matter expert and invited presenter for numerous research working groups and conferences. She was named Director of the RNCP in 2019. \nShona “Robin” Elgart is the Space Radiation Element Scientist for the NASA Human Research Program. Dr. Elgart has more than 20 years of research experience across multiple life-science disciplines\, including medical physics and radiation biology. She received a Bachelor’s degree in microbiology from the University of California at Santa Barbara and a Master’s and Doctorate in biomedical physics from the University of California at Los Angeles in the laboratory of Dr. Keisuke Iwamoto. Her dissertation focused on characterizing the DNA damage response following low-dose radiological exams in patient samples. Before joining The Space Radiation Element in April 2020\, Dr. Elgart served as a subject matter expert specializing in space radiation health risks for NASA’s Space Radiation Analysis Group (SRAG) where she directed and managed reviews of radiation health outcome evidence\, translated research findings into evidence-based operational radiation protection strategies\, and analyzed astronaut exposure and risk for the Radiation Health Office. She also has four years of mission operations experience as a Space Environment Officer and Radiation Mission Manager for Mission Control\nCenter in Houston. As the Element Scientist for the Space Radiation Element\, Dr. Elgart’s primary objective is to develop and execute a robust applied research strategy to meet the agency’s goal to put the first woman on the Moon and the first humans on Mars. \nJacqueline Garnier-Laplace is Deputy Head of the Division of Radiological Protection and Human Aspects of Nuclear Safety at the OECD Nuclear Energy Agency (NEA). She joined the Agency in May 2019. She serves as the Scientific Secretary for the Committee on Radiological Protection and Public Health (CRPPH)\, and a number of subsidiary groups such as the HighLevel Group on Low Dose Research. Previously\, she was the Deputy Director in charge of Research for Radiological Protection at the French Institute for radiological protection and nuclear safety (IRSN). During her 28-year career in the field of radiological protection\, she held various manager positions e.g.\, Deputy Director of the Environment (2015-2017)\, Head of Department on Research and Expertise on Environmental Risks (2007-2015). She is a member of the International Commission on Radiological Protection (ICRP). After being the scientific secretary of Committee 1 on “Effects of ionising radiation” for the period 2017-2021\, she is now serving Committee 4 on “Application of the Commission’s recommendations” until 2025. She\nhas (co)-authored ca. 110 peer-reviewed papers mainly dealing with various radiological\nprotection scientific issues. \nDr. Arthur M. Katz spent almost 40 years in the U.S. Department of Energy and predecessor agencies dealing with a wide range of energy and science topics including advanced nuclear reactors\, planning and international collaboration in fusion energy\, and fundamental biological and environmental research. In the Office of Biological and Environmental Research (OBER) he was responsible for managing projects that were part of DOE’s contribution to the Human Genome Program\, research into low dose radiation health effects\, and a variety of molecular imaging and structural biology projects. He was a member of the Low Dose Radiation Expert Subcommittee reporting to the Biological and Environmental Research Advisory Committee on Low Dose Radiation research. He received a PhD in chemistry from the University of Rochester\, 1969 and a M.S. in meteorology from MIT\, 1974. \nKaitlin Kelly-Reif is an epidemiologist in the NIOSH Division of Field Studies and Engineering\, Field Research Branch. She earned her masters and PhD in environmental and occupational epidemiology from the Gillings School of Global Public Health\, University of North Carolina Chapel Hill where she studied cancer among underground uranium miners in the Czech Republic. In 2014 she was a US National Science Foundation fellow at the Radiation Effects Research Foundation in Hiroshima\, Japan. Dr. Kelly-Reif leads chronic disease studies of workers exposed to ionizing radiation\, particulate matter\, and industrial chemicals. At NIOSH Dr. Kelly-Reif leads two large and historically important studies of radiation-exposed workers\, the US Colorado Plateau uranium miners’ study and the pooled US Nuclear Workers study. She also represents NIOSH in two international research consortia\, the Pooled Uranium Miners Analysis (PUMA) and the International Nuclear Workers Study (INWORKS). \nDominique Laurier\, PhD\, is the head of a research department on the biological and health effects of low-dose radiation exposure at the French Institute for Radiation Protection and Nuclear Safety (IRSN). He has 25 years of experience in the field of radiation epidemiology and has participated in numerous national and international research projects on the health effects of low-dose radiation exposure. He has been Chair of the Nuclear Energy Agency’s (NEA) High Level Group on Low Dose Research (HLG-LDR) since 2020. He has been a member of the main commission of the International Commission on Radiological Protection (ICRP) since 2017 and is currently the chairman of ICRP Committee 1\, as well as the French representative to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). \nAlexandra C. Miller\, PhD.\, is a senior scientist and research biologist in the Science Research Department (SRD) at the Armed Forces Radiobiology Research Institute (AFRRI) at the Uniformed Services University of the Health Sciences (USUHS). Dr. Miller is an internationally recognized researcher in the field of depleted uranium toxicity and late radiation biological effects. She is the AFRRI/SRD program leader of the chronic low dose radiation program otherwise known as the Combat Operations at Low Dose research program (COAL-R) at AFRRI. Dr. Miller is a trained radiation biologist educated at the State University of NY at Buffalo in the Roswell Park Cancer Division. Dr. Miller has over 74 publications\, 1 book on Depleted uranium\, and multiple book chapters on low dose radiation and uranium metal toxicity. She holds adjunct or visiting scientist positions at USUHS Department of Radiology and Radiation Science\, Columbia University Center for Radiological Research NY\, NYU Langone Medical Center\, and the Department of Chemistry and Life Science at US Military Academy West Point. A long-time AFRRI scientist\, Dr. Miller has publications in the areas of radiation biochemistry\, radiation protection\, radiation mechanisms\, military medicine\, depleted uranium and heavy metal biological effects. Currently she leads funded-studies on low dose mixed field neutron effects\, radiation cardiotoxicity\, radiation countermeasure development\, and use of 3-D models to assess low dose neurological responses. Dr. Miller serves as the lead AFRRI member of the NATO Science and Technology Organizations (STO) Working Group on Radiation BioeffectsT RTG291 and was recently invited to serve as a Department of Defense member of the ICCVAM – Consideration of Alternate Methods Working Group.
URL:https://globalbiodefense.com/event/developing-a-long-term-strategy-for-low-dose-radiation-research-in-the-u-s/
LOCATION:https://www.nationalacademies.org/event/09-24-2021/developing-a-long-term-strategy-for-low-dose-radiation-research-in-the-united-states-meeting-4-september-24-2021
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210924T094500
DTEND;TZID=America/New_York:20210924T160000
DTSTAMP:20210812T195235Z
CREATED:20210812T195020Z
LAST-MODIFIED:20210812T195235Z
UID:49495-1632476700-1632499200@globalbiodefense.com
SUMMARY:Review of Third-Party Research Risk: Is There a Role for IRBs?
DESCRIPTION:“Review of Third-Party Research Risk: Is There a Role for IRBs?\,” an HHS Office for Human Research Protections (OHRP) Exploratory workshop\, will be livecast on 24 September 2021. \nThe research community has generally focused on the protection of human research subjects as defined by the\nCommon Rule. However\, sometimes the conduct of research can have an impact on people who are third parties\nand who do not meet the definition of human subjects. This meeting will explore who some of the impacted parties are and what types of risks they might face in various types of research. It will further explore the idea of expanding regulatory protections to cover third parties in some circumstances. Panelists will discuss whether and what support for this idea already exists in the field of research ethics and whether institutional review boards (IRBs) have a role to play in oversight of such protections should they be warranted. \nHighlighted sessions include: \n\nPanelists will consider whether researchers and the research community have a responsibility to protect third parties and if so\, in what capacity.\nResearch Studies That Do Not Directly Involve Human Subjects\nThird-Party Risk in Clinical Research Trials\nEnsuring Privacy\, Building Trust: Collecting\, Processing\, and Sharing Third-Party Information in Social\nand Behavioral Health Research\nEthical Considerations for Third-Party Risk in Research\nLimiting Non-Consenting Third Parties to Reasonable Research Risks\nPublic Risk Perception and the Creation of Clear Communications\nReviewing Third-Party Risks: A Proposed Framework for IRBs (and Researchers)\nAre IRBs the Right Oversight Bodies for Protecting Third Parties?\n\nVideos of each session will be available on the HHS OHRP website after the event. All Exploratory Workshop sessions meet the Certified IRB Professional (CIP) recertification guidelines exit disclaimer icon and are eligible for a maximum of 5 hours of credits.
URL:https://globalbiodefense.com/event/review-of-third-party-research-risk-is-there-a-role-for-irbs/
LOCATION:https://videocast.nih.gov/watch=41987
CATEGORIES:Conference,Continuing Education
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/ohrp-review-third-party-research-risk-role-irb-clinical-trial-bioethics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210924T080000
DTEND;TZID=America/Los_Angeles:20210924T170000
DTSTAMP:20210924T220010Z
CREATED:20210924T215927Z
LAST-MODIFIED:20210924T220010Z
UID:49782-1632470400-1632502800@globalbiodefense.com
SUMMARY:ASHG 2021 - American Society of Human Genetics
DESCRIPTION:The annual meeting of the American Society of Human Genetics will convene in a virtual format 12-14 October 2021. \nWith over 7\,000 expected attendees\, the ASHG 2021 Virtual Meeting is a diverse\, global community that engages and welcomes diverse voices and alliances among scientists of all nationalities. \nHighlighted posters or presentations include: \n\nBuilding Genomic Data Science Capacity for Health Discovery and Innovation in Africa\nBenefits of Hybrid Capture for Viral Surveillance of SARS-CoV-2\nEmerging public policy and perspectives on biometrics (including DNA and facial imaging) in the US\nDownregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children\nUsing metagenomics to assess global levels of antimicrobial resistance\nHLA Fine Mapping and Genetic Risk Factors in Tuberculosis\nGenotype-by-infection interactions: Single cell RNASeq profiling of in-vivo host immune response to malaria reveals cell type and infection-specific eQTLs\nHigh-resolution genomic architecture of COVID-19 severe disease using multi-ethnic whole genome sequencing data\nA comprehensive repository of clinical\, lab assay\, and genetic data for studies of innate and adaptive immune responses during acute COVID-19 infection and convalescence\nCodon bias analysis of wildtype SARS-CoV-2 and prevalent variants indicates a mutational trajectory independent of human pulmonary tissue and genomic bias\nCommon and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity\nIdentification of causal genetic variants in invasive pneumococcal diseases by exome analysis in children\nAnalysis of genetic variants of SARS-CoV-2 host factors ACE2\, NRP1\, TMPRSS2\, and FURIN in Japanese population from IRUD whole-exome sequencing data\nThe long-term effect of SARS-CoV-2 infection on host genetic regulation\nA computational approach for detecting physiological homogeneity in the midst of genetic heterogeneity\nA genome-wide association study identifies two novel loci for respiratory infection with Pseudomonas aeruginosa\nData-driven analysis exploring age and sex effects on gene expression for dengue hemorrhagic fever\nAssessing the potential correlation of polymorphisms in the IL6R gene with relative IL-6 elevation in severely ill COVID-19 patients\nAssociation of CXCR6 with COVID-19 severity: host genetic factors underlying transcriptomic regulation in 3p21.31 locus\n\nThe conference offers: \n\n16 Plenary abstract talks (abstract-driven)\n198 Platform talks (abstract-driven)\n16 Invited sessions (member proposed sessions)\n80 rapid-fire poster talks selected from the top scoring posters\nAlmost 2000 dynamic posters (abstract-driven) with a dedicated time slot on Monday\, October 18 for author presentations and interactions\nThe Presidential Symposium and a late breaking abstract-driven plenary session\nEnhanced capabilities for virtual networking through video and chat channels\nOpportunities for collaboration with an interdisciplinary network of emerging and leading scientists\nIndustry-driven technology solutions\nLive and on-demand content\nCEUs and CMEs available\n\nASHG is a global interdisciplinary community of 8\,000 researchers who investigate fundamental working of genes and genomic variation\, and who translate new genetic knowledge to propel biomedical research\, improve human health\, and understand our common ancestral origins. \nPlease visit the ASHG 2021 Meeting website for more information. \n 
URL:https://globalbiodefense.com/event/ashg-2021-american-society-of-human-genetics/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210921T100000
DTEND;TZID=America/New_York:20210924T143000
DTSTAMP:20210923T214225Z
CREATED:20210923T214225Z
LAST-MODIFIED:20210923T214225Z
UID:49731-1632218400-1632493800@globalbiodefense.com
SUMMARY:Towards a Post-Pandemic World: Lessons from COVID-19 for Now and the Future
DESCRIPTION:This workshop will extract lessons from the ongoing global COVID-19 response for better recovery now and better future preparedness.\n\n\nSeptember 21st – 24th\, 10:00am – 2:30pm EDT  \nJoin the Forum on Microbial Threats for an exciting virtual conversation about what we’ve learned from 15 months of living through a global pandemic. The workshop will broadly examine responses to COVID-19 in the U.S. and abroad\, and will host retrospective and prospective discussions on the broad impacts of the pandemic on human health and society. Events will highlight successes\, missed opportunities\, and emerging data in order to extract key understandings that leaders in governments\, public health systems\, the private sector\, and communities can incorporate into their ongoing pandemic responses now with a view towards enhancing resilience and preparedness for future outbreaks. \nIndividual workshop sessions will focus on: \n\nAnticipated long-term effects of COVID-19 (Day 1)\nTrust\, engagement\, and misinformation in public health (Day 2)\nKey questions on interventions and recovery from COVID-19 (Day 3)\nBuilding capacities for better pandemic preparedness and response (Day 4)\n\nFor the agenda and more information\, click here. \n**CLICK HERE TO WATCH THE WORKSHOP LIVESTREAM**
URL:https://globalbiodefense.com/event/towards-a-post-pandemic-world-lessons-from-covid-19-for-now-and-the-future/
LOCATION:https://www.nationalacademies.org/event/07-27-2021/moving-past-covid-19-lessons-learned-from-responses-around-the-world
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/2691bef0e6043b48472f020f05a0856a.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210831
DTEND;VALUE=DATE:20210901
DTSTAMP:20210812T193538Z
CREATED:20210812T193538Z
LAST-MODIFIED:20210812T193538Z
UID:49492-1630368000-1630454399@globalbiodefense.com
SUMMARY:2021 Federal Wearables Summit
DESCRIPTION:The 2021 Federal Wearables Summit is a broad effort supported by several federal agencies and intended to bring the discussion on wearable sensors for monitoring health and health quality closer to all people. The Summit is open to the public and will address issues of interest\, such as the perspectives of patients and medical care professionals\, data security specialists\, the regulatory bodies\, and federal agencies. \nHighlighted panel discussions include: \n\nMedical Care Provider’s Perspective\nTechnology and The Consumer Health Care Experience Panel\nData Security\nFederally Funded Research & Development Panel\nStakeholder Panel – The Future of Wearables for Health Monitoring\nWearables and Behavior\n\nVisit the 2021 Federal Wearables Summit website for more information. \n 
URL:https://globalbiodefense.com/event/2021-federal-wearables-summit/
LOCATION:
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/federal-wearables-summit-hhs-aspr-barda-drive.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210826T130000
DTEND;TZID=America/New_York:20210826T140000
DTSTAMP:20210812T201108Z
CREATED:20210812T201108Z
LAST-MODIFIED:20210812T201108Z
UID:49500-1629982800-1629986400@globalbiodefense.com
SUMMARY:Red-Teaming the Post-Covid-19 Biological Weapon Threat Landscape
DESCRIPTION:Join us on August 26 for a CSWMD Spotlight Webinar on “Red Teaming the Post-COVID-19 Biological Weapons Threat Landscape” with Gary Ackerman and Ted Plasse. \nThe Spotlight speakers will describe a project that utilized Asynchronous Strategic Dynamics Red Teaming (ASDyRT) to investigate the extent to which COVID-19 might impact the strategic decision making of 30 states that currently do not possess an offensive BW program\, to examine the decision elements that might precipitate changes in current strategic BW decisions by state leaders\, and to explore the operational characteristics of any new programs. Results and the implications for BW monitoring\, defense and nonproliferation will be discussed. \nThe COVID-19 pandemic has created unprecedented global disruption\, including loss of life\, economic crises\, and political disagreements. Beyond these short- and medium-term challenges\, the pandemic may have shifted the strategic dynamics surrounding biological weapons (BW). Will some leaders be more likely to put their countries on the path to pursuing biological weapons? Will the pandemic make other countries even less interested in having anything to do with biological weapons? \nThis Spotlight Webinar hosted online by the National Defense University (NDU) Center for the Study of Weapons of Mass Destruction (CSWMD). \nIf you have any questions about the event\, please contact the CSWMD Admin staff at WMDCenter@ndu.edu. \nSpeaker Biographies\nGary Ackerman is an Associate Professor in the College of Emergency Preparedness\, Homeland Security and Cybersecurity at SUNY\, Albany. In addition to his faculty position at Albany\, he is Associate Dean for Research in the College\, and the founding director of the Center for Advanced Red Teaming (CART)\, the first research center devoted to improving the science and practice of red teaming. Much of his work is centered on the motivations and capabilities for adversaries to acquire and use chemical\, biological\, radiological or nuclear weapons\, as well as other emerging technologies. He has an M.A. in International Relations (Strategic Studies) from Yale University and a Ph.D. in War Studies from King’s College in London. \nTheodore R. Plasse is the Analysis and Planning Team Chief for USSOCOM CWMD Support Program (SCSP) and a recognized Biological Warfare expert. He has a B.S. in Biology from Siena College of New York\, a M.S. in Ecology from Central Washington University\, Washington. Mr. Plasse is a retired US Army Military Intelligence Officer and has over 25 years’ experience in the IC working WMD issues. \nModerated by Sarah Jacobs Gamberini\, Policy Fellow\, CSWMD.
URL:https://globalbiodefense.com/event/red-teaming-the-post-covid-19-biological-weapon-threat-landscape/
LOCATION:
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210825
DTEND;VALUE=DATE:20210827
DTSTAMP:20210812T213643Z
CREATED:20210812T213643Z
LAST-MODIFIED:20210812T213643Z
UID:49508-1629849600-1630022399@globalbiodefense.com
SUMMARY:Advanced Diagnostics for Infectious Disease
DESCRIPTION:CHI’s 13th Annual Advanced Diagnostics for Infectious Disease\, part of the Next Generation Dx Summit\, will take place August 25-26\, 2021 with flexible virtual and in-person participation options. \nLeaders working in the clinical lab\, research\, biotech\, and pharma will come together to showcase the latest in diagnostic technology and find solutions for the biggest challenges facing the clinical lab\, including managing workflow\, incorporating NGS and molecular testing\, gaining reimbursement and regulatory approval\, and more. \nHighlighted topics include: \n\nThe NIH Rapid Acceleration of Diagnostics (RADx) Initiative: A Public Program with Industrial Management\nThe Pitfalls and Challenges in Estimating SARS-CoV-2 Viral Load\nRapid Acceleration of Diagnostic Development\nCaveats of testing from a Respiratory Viral Pandemic\nThe Value of SARS-CoV-2 Sequencing and Variant Detection for the Clinical Laboratory\nDetection of ESKAPE Pathogens and Select Antimicrobial Resistance Determinants from Wound Specimens\nPrototyping rapid and manufacturable AST devices\n\nPlease visit the Next Generation Dx Summit website for more information.
URL:https://globalbiodefense.com/event/advanced-diagnostics-for-infectious-disease/
LOCATION:Grand Hyatt Washington\, 1000 H St NW\, Washington DC\, 20001\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210824
DTEND;VALUE=DATE:20210826
DTSTAMP:20210812T214347Z
CREATED:20210812T214321Z
LAST-MODIFIED:20210812T214347Z
UID:49512-1629763200-1629935999@globalbiodefense.com
SUMMARY:Enabling Point-of-Care Diagnostics
DESCRIPTION:CHI’s Annual Enabling Point-of-Care Diagnostics program\, part of the Next Generation Dx Summit\, will take place August 24-25\, 2021 with flexible virtual and in-person participation options. \nPoint-of-care testing stands to revolutionize all aspects of medicine by providing rapid test results\, patient access to data and a broad range of tests available. The need for self-testing and rapid turnaround was brought to light during the COVID-19 pandemic and the field is expanding to enable and ensure a steady supply chain\, reliable results\, interconnectivity of platforms and management of health data by consumers. The goal of the POCT community is to meet the current demands in the market. \nHighlighted topics include: \n\nHow Connected Diagnostics and Care Automation Will Cut a Trillion from the Annual Global Healthcare Spend\nHome COVID-19 Testing: Strategies for Measurements That Are Fit for Purpose\nEngineering Biology for Diagnostic Solutions\nPrinciples and Practice of Pandemic Diagnostics – Lessons Learned from COVID-19\nAmplification-Free Detection of SARS-CoV-2 with CRISPR-Cas13a and Mobile Phone Microscopy\nFacing the Pandemic in Brazil from Massive Population Testing to New Tools for Genomic and Immunology Surveillance to the New SARS-CoV-2 Variants of Concern\nMicrofluidic Lab on Chip for Rapid Detection of Pathogens\nPoint-of-Care Molecular Diagnostics for Infectious Diseases\nPoint-of-Care Testing Outside of the Hospital Environment: Street Medicine and Beyond\nCLSI Resources for Validation\, Implementation\, and Management of New Tests\nCo-Diagnostics New Eikon Platform Provides PCR Results for At Home and Point of Care Testing\nPoint-of-Care Infectious Disease Molecular Testing in the Age of COVID-19\nTesting and Recommendations for Future Emerging Outbreaks: Advocacy\, Education and Clinical Practice\n\nPlease visit the Next Generation Dx Summit website for more information.
URL:https://globalbiodefense.com/event/enabling-point-of-care-diagnostics/
LOCATION:Grand Hyatt Washington\, 1000 H St NW\, Washington DC\, 20001\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210818T110000
DTEND;TZID=America/New_York:20210818T120000
DTSTAMP:20210812T201705Z
CREATED:20210812T201705Z
LAST-MODIFIED:20210812T201705Z
UID:49503-1629284400-1629288000@globalbiodefense.com
SUMMARY:The Integrated Chemical Environment: Computational Tools and Curated Data to Support Toxicity Assessment
DESCRIPTION:The Office of Data Science of the National Institute of Environmental Health Sciences will present a webinar on “The Integrated Chemical Environment: Computational Tools and Curated Data to Support Toxicity Assessment” on Wednesday\, August 18\, at 11:00 a.m. EDT. \nThe National Toxicology Program’s Integrated Chemical Environment (ICE) provides access to high-quality\, curated\, regulatory-relevant toxicological and chemical data and in silico predictions of chemical properties to support chemical evaluations\, data integration\, and model development. In this webinar\, John Rooney\, ILS (contractor supporting NICEATM)\, will describe how ICE uses annotations and graphic displays to provide context for high-throughput assay results. He will demonstrate some ICE tools and present case studies showing how these tools can be used for chemical analyses and comparisons. \nThe webinar is free and open to the public.
URL:https://globalbiodefense.com/event/the-integrated-chemical-environment-computational-tools-and-curated-data-to-support-toxicity-assessment/
LOCATION:https://nih.zoomgov.com/j/1607258769#success
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210707
DTEND;VALUE=DATE:20210710
DTSTAMP:20210226T214129Z
CREATED:20210226T214129Z
LAST-MODIFIED:20210226T214129Z
UID:48691-1625616000-1625875199@globalbiodefense.com
SUMMARY:New Approaches and Concepts in Microbiology
DESCRIPTION:The New Approaches and Concepts in Microbiology will take place 7-9 July 2021 in a virtual format. \nThe event will cover a broad range of topics in microbiology\, including antibiotic-related research\, bacterial communities and microbiome\, cell biology\, regulation & signalling\, pathogenesis and evolution. Emphasis will be placed on novel approaches and technologies (from systems-based to single-cell) that drive each field or have the potential to revolutionise future research in microbiology. \nThis must-attend event for scientists working with bacteria and new technologies. The focus remains on the interface of new technologies and new biology in bacteria\, but the thematic areas change and speaker line-ups do not overlap between consecutive symposia. \nThis symposium aims at bridging the gap between traditional microbiology and novel technologies\, by exposing microbiologists to new ways of addressing their hypotheses. At the same time\, it provides a platform for systems or technology experts to get a better understanding of the important questions in the field. \nHighlighted sessions and focus areas include:\nBacterial systems biology\nCell biology and protein machineries\nRegulation\, signalling and transcriptional networks\nPathogenesis and infection\nAntibiotic action-resistance-persistance\nMicrobial communities / microbiotas / symbiosis\nEvolution and ecology \nPlease visit EMBO | EMBL’s New Approaches and Concepts in Microbiology page for more information.
URL:https://globalbiodefense.com/event/new-approaches-and-concepts-in-microbiology/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210610
DTSTAMP:20210124T013522Z
CREATED:20210124T013522Z
LAST-MODIFIED:20210124T013522Z
UID:48301-1623110400-1623283199@globalbiodefense.com
SUMMARY:Pivotal Interfaces of Environmental Health and Infectious Disease Research to Inform Responses to Outbreaks
DESCRIPTION:This workshop will explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions. \nAn ad hoc planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and convene a workshop to explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions\, through the following questions: \n1) How can advances in environmental exposure assessment be applied to identify\, predict\, or monitor critical pathways by which humans are exposed to infectious agents? \n2)  How can recent advances in climate and environmental health modeling techniques be applied to better understand the biology of pathogens\, vectors\, and hosts; predict transmission dynamics; and provide early warning of emerging infectious diseases? \n3) How can environmental pollutants exposure models and data integration approaches be leveraged to predict population vulnerability/risk to infection? \n4) How sensitive is the initial emergence of infectious disease outbreaks to variations in environmental conditions? \nThe presentations and discussions at the workshop will be documented in a workshop proceedings\, written by a designated rapporteur in accordance with institutional guidelines.
URL:https://globalbiodefense.com/event/pivotal-interfaces-of-environmental-health-and-infectious-disease-research-to-inform-responses-to-outbreaks/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210527T153000
DTEND;TZID=Europe/London:20210527T163000
DTSTAMP:20210518T201503Z
CREATED:20210518T201503Z
LAST-MODIFIED:20210518T201503Z
UID:49248-1622129400-1622133000@globalbiodefense.com
SUMMARY:Maximum Containment Labs Around the World
DESCRIPTION:Join Dr. Filippa Lentzos and Dr. Gregory D. Koblentz for a briefing on 27 May 2021 on a new resource on global BSL4 labs and biorisk management policies. \nThis public webinar\, held on the side lines of the seventy-fourth World Health Assembly meeting\, will launch globalbiolabs.org\, an interactive web-based map of global Biosafety Level-4 facilities and biorisk management policies. An accompanying policy brief\, entitled ‘Mapping Maximum Biological Containment Labs Globally’\, will also be released. \n 
URL:https://globalbiodefense.com/event/maximum-containment-labs-around-the-world/
LOCATION:https://us02web.zoom.us/webinar/register/WN_HuZbZ7SbS8OvljyRYr9-nA
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20210527T133000
DTEND;TZID=Europe/Paris:20210527T144500
DTSTAMP:20210518T223618Z
CREATED:20210501T222833Z
LAST-MODIFIED:20210518T223618Z
UID:49253-1622122200-1622126700@globalbiodefense.com
SUMMARY:Advancing Gender Perspectives in the Biological Weapons Convention
DESCRIPTION:The International Gender Champions Disarmament Impact Group and the BWC Implementation Support Unit welcome you to an interactive discussion on 27 May on the relevance of gender perspectives to the implementation of the Biological Weapons Convention. \nThe discussion will address recent initiatives to improve women’s meaningful participation in the BWC\, as well as research on sex-specific and gendered impacts of biological weapons. \nPanelists will take stock of how gender perspectives are already being incorporated into BWC discussions and\, in view of the forthcoming Ninth BWC Review Conference\, how they can be further promoted and strengthened in future BWC work programmes. \nThe event will also mark the launch of a new factsheet by the Disarmament Impact Group on “Gender and Biological Weapons”. \n 
URL:https://globalbiodefense.com/event/advancing-gender-perspectives-in-the-biological-weapons-convention/
LOCATION:https://rtce-unog.webex.com/mw3300/mywebex/default.do?nomenu=true&siteurl=rtce-unog&service=6&rnd=0.4655756273962446&main_url=https%3A%2F%2Frtce-unog.webex.com%2Fec3300%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26%26%26EMK%3D4832534b00000004346873833f32d707b10d18ee70fc3d5c8c3d215ec63e9ede0c9f7e79edd173a2%26siteurl%3Drtce-unog%26confViewID%3D194014003524017497%26encryptTicket%3DSDJTSwAAAAQm5DyOP2TNxCQgIiR4ZmkiGlbFK2NrgnXV1zaYNmQKdw2%26
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210526T110000
DTEND;TZID=America/New_York:20210526T120000
DTSTAMP:20210525T214033Z
CREATED:20210516T211111Z
LAST-MODIFIED:20210525T214033Z
UID:49261-1622026800-1622030400@globalbiodefense.com
SUMMARY:U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats
DESCRIPTION:The Capitol Hill Steering Committee on Pandemic Preparedness and Health Security will convene for a webcast event on “U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats” on Wednesday\, May 26\, 2021. \nThis webinar will explore how the federal government can prioritize investments in available and future technologies to ensure nothing like the Covid-19 pandemic\, or worse\, could ever happen again. \nThe Steering Committee hosts monthly events focused on lessons learned from responses to natural\, man-made\, and other complex health emergencies\, such as the COVID-19 pandemic\, and how to better mitigate and respond to future health crises. \nThe Steering Committee is sponsored and managed by Johns Hopkins Center for Health Security. Six United States Senators serve as Honorary Senate Co-Chairs\, Four United States House of Representatives serve as Honorary House Co-Chairs and 4 former federal government public health leaders serve as Honorary Founding Members. \nHonorary Senate Co-Chairs \n\nSenator Tammy Baldwin (D-WI)\nSenator Richard Burr (R-NC)\nSenator Ben Cardin (D-MD)\nSenator Bob Casey (D-PA)\nSenator Cindy Hyde-Smith (R-MS)\n\nSenator Chris Van Hollen (D-MD)\n\n\nHonorary House of Representatives Co-Chairs \n\nRepresentative Rosa DeLauro (D-CT)\nRepresentative Anna Eshoo (D-CA)\nRepresentative Andy Harris (R-MD)\nRepresentative Richard Hudson (R-NC)\n\nHonorary Founding Members \n\nSusan Brooks\, JD\, Former U.S. House of Representative (R-IN)\nStephen Redd\, MD\, Former Deputy Director for Public Health Service and Implementation Science\, US Centers for Disease Control and Prevention; Rear Admiral Retired\, US Public Health Service\nKathleen Sebelius\, MPA\, Former Secretary\, US Department of Health and Human Services\, former Governor of Kansas\nW. Craig Vanderwagen\, MD\, Former Assistant Secretary for Preparedness and Response\, US Department of Health and Human Services\, Rear Admiral Retired\, US Public Health Service
URL:https://globalbiodefense.com/event/u-s-leadership-for-a-pandemic-free-future-technologies-to-end-biological-threats/
LOCATION:https://jh.zoom.us/webinar/register/WN_bE6b6oFDSyS3C2a3WWEleA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210520T090000
DTEND;TZID=America/New_York:20210520T110000
DTSTAMP:20210520T140902Z
CREATED:20210501T140556Z
LAST-MODIFIED:20210520T140902Z
UID:49256-1621501200-1621508400@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join Dr. Tom Frieden and the Prevent Epidemics team of Resolve to Save Lives\, an initiative of Vital Strategies\, to discuss lessons from past outbreaks\, preparedness successes\, and the need to invest and prioritize funding to fight the next pandemic. The event will call on political and public health leaders to increase global collaboration and work together at the global\, regional\, country\, and local levels to build a more resilient response to future health emergencies. For more information pandemic preparedness\, read our recent report Epidemics that Didn’t Happen.
URL:https://globalbiodefense.com/event/the-future-of-global-health-security/
LOCATION:https://preventepidemics.org/globalhealthsecurityevent/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20210518T222659Z
CREATED:20210318T222200Z
LAST-MODIFIED:20210518T222659Z
UID:49251-1621296000-1621382399@globalbiodefense.com
SUMMARY:CBRNE Research and Innovation 2021
DESCRIPTION:The International e-Conference on CBRNE Research & Innovation will take place May 18\, 2021. \nHighlighted topics include: \n\nRecycling protective garments processes and techniques used for decontaminating and removing unwanted organic substances\nOnline tools for assessment of factors associated with SARS-CoV-2 infection\, and evaluation of new prophylactic and therapeutic drug regimens against COVID-19\nDiscovery tools in preparedness and response to NRBC threats\nPReparedness against CBRNE threats through cOmmon Approaches between security praCTItioners and the VulnerablE civil society (PROACTIVE)\nEuropean Network of CBRN Training Centers: just-in-time training and evolving training methodologies for first responders\n\nThe virtual format event builds on the success of the first 3 international conferences which tool place in Antibes (2015)\, Lyon (2017) and Nantes (2019) and will serve as a professional bridge until the next in-person conference at Lille in May 2022. \nhttps://cbrneconference.fr/ \n  \n 
URL:https://globalbiodefense.com/event/cbrne-research-and-innovation-2021/
LOCATION:https://cbrneconference.fr/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210511T110000
DTEND;TZID=America/New_York:20210511T150000
DTSTAMP:20201127T193923Z
CREATED:20201127T193923Z
LAST-MODIFIED:20201127T193923Z
UID:48065-1620730800-1620745200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 4
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on May 11\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider ways the thoughtful and deliberate use of new technologies could improve the clinical trials enterprise and support goals outline in prior webinar sessions. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030. Key priority challenges and opportunities framing the 2030 agenda are: \n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nPlanning Committee\n\nSteven Galson (Co-Chair)\, Amgen\nEster Krofah (Co-Chair)\, FasterCures\, Milken Institute\nAmy Abernethy\, Office of the Comissioner\, FDA\nAnita LaFrance Allen\, University of Pennsylvania\nChristopher P. Austin\, National Center for Advancing Translational Sciences\, NIH\nHoward A. Burris\, Sarah Cannon\nLuther T. Clark\, Merck & Co.\, Inc.\nGiselle Corbie-Smith\, The University of North Carolina at Chapel Hill\nM. Khair ElZarrad\, Center for Drug Evaluation and Research\, FDA\nJennifer Goldsack\, Digital Medicine Society\nRichard A. Moscicki\, PhRMA\nAmy Patterson\, National Heart\, Lung\, and Blood Institute\, NIH\nJoseph Scheeren\, Critical Path Institute\nAnantha Shekhar\, University of Pittsburgh\nPamela Tenaerts\, Clinical Trials Transformation Initiative\nChristopher Yoo\, Systems Oncology\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-4/
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210504T160000
DTEND;TZID=America/Los_Angeles:20210504T180000
DTSTAMP:20240623T231246Z
CREATED:20210225T161815Z
LAST-MODIFIED:20240623T231246Z
UID:48633-1620144000-1620151200@globalbiodefense.com
SUMMARY:Reporting Science to Public & How 'Science' Adapts to the Pandemic
DESCRIPTION:A virtual presentation on “Reporting Science to Public & How ‘Science’ Adapts to the Pandemic” will be held on May 4\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \n~ Stephen Smith (Washington Post Health and Science Editor) \n~ Valda Vinson\, PhD (Science Editor) – Valda Vinson is Editor (Research) at Science. She came to the United States as a Fulbright scholar and after completing a Ph.D and post-doctoral studies\, spent 2 years as a Senior Lecturer at the University of the Western Cape. She started her career in publishing when she joined the Science staff in 1999. Since then\, she has handled research papers in the areas of structural biology\, biochemistry\, and biophysics as an Associate and Senior Editor. In 2013 Dr. Vinson became Deputy Editor\, overseeing research content in the areas of cellular and molecular biology and biomedicine\, and in 2018 was named Editor\, Research. As Editor she works with Life Science editors to attract and select exciting research papers and reviews\, while following standards that support transparency and reproducibility. She also works with others on the editorial management team on editorial policies at Science and is involved in initiatives that bring together stake-holders within the publishing industry to discuss policies. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/reporting-science-to-public-how-science-adapts-to-the-pandemic/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210424
DTSTAMP:20200323T175402Z
CREATED:20200228T040200Z
LAST-MODIFIED:20200323T175402Z
UID:40443-1618876800-1619222399@globalbiodefense.com
SUMMARY:ABSA's 1st Biosecurity Symposium
DESCRIPTION:Due to the COVID-19 pandemic\, ABSA’s 1st Biosecurity Symposium has been rescheduled and will now take place 20-23 April 2020 in Minneapolis\, MN. \nABSA International’s 1st Biosecurity Symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge\, and to learn from each other. \nThe agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. The symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nPlease visit ABSA’s 1st Biosecurity Symposium website for more information. \n 
URL:https://globalbiodefense.com/event/absas-1st-biosecurity-symposium/
LOCATION:Renaissance Depot Hotel\, 225 3rd Ave S\, Minneapolis\, MN\, 55401\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210422
DTSTAMP:20210227T184218Z
CREATED:20210227T184218Z
LAST-MODIFIED:20210227T184218Z
UID:48698-1618876800-1619049599@globalbiodefense.com
SUMMARY:APBI 2021 - APG Advanced Planning Briefing to Industry
DESCRIPTION:Team Aberdeen Proving Ground (APG) is hosting the APG Advanced Planning Briefing to Industry (APBI) on April 20-21\, 2021 via virtual format. \nThe goal of the APG APBI is to describe for industry potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. \nAdditional details will be posted at beta.SAM.gov as updates become available.
URL:https://globalbiodefense.com/event/apbi-2021-apg-advanced-planning-briefing-to-industry/
LOCATION:
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210407T183000
DTEND;TZID=America/New_York:20210407T200000
DTSTAMP:20240118T180225Z
CREATED:20210308T082324Z
LAST-MODIFIED:20240118T180225Z
UID:48783-1617820200-1617825600@globalbiodefense.com
SUMMARY:Schar School of Policy and Government: Master’s and Certificate Virtual Open House
DESCRIPTION:Master’s and Certificate Virtual Open House\nApril 7\, 2021 6:30 p.m. – 8:00 p.m. ET \nLearn more about the Schar School of Policy and Government and our academic programs at a virtual open house. The online session will provide an overview of our master’s degree and graduate certificate programs\, student services\, and admissions requirements. \nLearn more: http://bit.ly/scharopenhouse2021
URL:https://globalbiodefense.com/event/schar-school-of-policy-and-government-masters-and-certificate-virtual-open-house/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/03/gmu-schar-school-open-house-large-1200.png
END:VEVENT
END:VCALENDAR